We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects

This study has been withdrawn prior to enrollment.
(Could not obtain drug supply from manufacturer)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01343641
First Posted: April 28, 2011
Last Update Posted: April 27, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
National Institutes of Health (NIH)
Merck Sharp & Dohme Corp.
Information provided by:
University of Virginia
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: April 2010
  Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)